-
Abstract Number: PB1261
Tailored Anticoagulant Treatment after a First Venous Thromboembolism: Protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) Study, a Cohort Based Randomized Controlled Trial
-
Abstract Number: PB0676
Tailoring the Effect of Antithrombin-targeting Therapy in Hemophilia A Using in Silico Thrombin Generation
-
Abstract Number: PB0656
Targeted CRISPR/Cas9-mediated Gene Addition to a Safe Harbor in Placental Cells for the Treatment of Hemophilia A
-
Abstract Number: PB0869
Targeted Next Generation Sequencing for the Diagnosis of Patients with Inherited Thrombocytopenias
-
Abstract Number: PB1032
Targeted Proteasomal Degradation of Platelet BTK and TEC as a Novel Approach in Thrombosis Prevention
-
Abstract Number: OC 36.4
Targeted Protein Biomarker Discovery to Predict Cardiovascular Outcome in Peripheral Artery Disease
-
Abstract Number: OC 60.3
Targeting Coagulation Factor Xa and IIa Differentially Regulate Inflammation
-
Abstract Number: PB1037
Targeting Pathways of Mitochondrial Neutrophil Extracellular Trap Formation to Inhibit Progression of Abdominal Aortic Aneurysms in Preclinical Models
-
Abstract Number: PB0148
Targeting Thymidine Phosphorylase May Be a Novel Therapy for COVID-19
-
Abstract Number: PB0199
TEG/ROTEM: A Tool to Aid in the Diagnosis and Management of COVID 19 Coagulopathies – A Systematic Review
-
Abstract Number: PB0597
Telemedicine in Hemophilia: A Comprehensive Review
-
Abstract Number: LPB0083
Temporal Assessment of Platelet Proteome and fFnction during ex vivo Anticoagulation
-
Abstract Number: PO159
Tetralogy of Fallot with Thrombolytic Ongoing Processes: A Case Report
-
Abstract Number: OC 58.1
The “Double-edged Sword”: The Role of LMWPTP in Platelet Hyperactivity in Cancer Patients
-
Abstract Number: PB1278
The Accelerated Regimen of Low Dose Recombinant Tissue-type Plasminogen for the Treatment of Acute Pulmonary Embolism: A Case Series from Vietnam
-
Abstract Number: PB0875
The Analysis of Platelet Functional Activity in Patients with Thrombocytopenia
-
Abstract Number: PB0293
The Assessment of Thrombotic Complication in Patients with COVID-19
-
Abstract Number: PB1126
The Association among von Willebrand Factor, ADAMTS-13, D-dimer, and Soluble P-selectin with Venous Thromboembolism Incidence in Cancer Patients: Systematic Review and Meta-analysis
-
Abstract Number: LPB0117
The Association of Emicizumab and rFVIIa for Major Orthopaedic Surgery
-
Abstract Number: PB0794
The Bacteria-associated Thrombosis, Thrombophlebitis and LEmierre Syndrome (BATTLE) Registry: Background and Rationale
-
Abstract Number: PO142
The Case of Acquired Haemophilia A
-
Abstract Number: PO191
The Case of Obstetric APS – A Therapeutic Challenge
-
Abstract Number: PB0229
The Characteristics and Outcomes of Critically Ill Patients with COVID-19 who Received Systemic Thrombolysis for Presumed Pulmonary Embolism: An Observational Study
-
Abstract Number: PB0548
The Clinical Bleeding Phenotype of Patients with Non-severe Hemophilia A and B
-
Abstract Number: PB0843
The Clinical Burden of Congenital and Immune-mediated Thrombotic Thrombocytopenic Purpura: A Retrospective Cohort Analysis
-
Abstract Number: PB0013
The Coagulation and Fibrinolisys Changes Undergoing the Ramipril and Losartan Treatment of Concomitant Arterial Hypertension and Diabetes Mellitus Type 2
-
Abstract Number: PB0065
The Coagulation Balance: Intracranial Hemorrhage in a Patient with Antithrombin Deficiency. A Case Report
-
Abstract Number: PB0240
The Comparison of Different Coagulation Markers in Thrombosis Prediction in COVID-19 Pneumonia
-
Abstract Number: PB0285
The Comparison of ISTH Criteria for Disseminated Intravascular Coagulation (DIC) Scale, Padua Scale, D-dimer and Fibrinogen Like the Best Predictor of Thrombosis in COVID-19 Pneumonia
-
Abstract Number: PB0866
The Copenhagen Founder Variant GP1BA c.58T>G is Causal of Monoallelic Bernard-Soulier Syndrome
-
Abstract Number: PB0814
The Correlation of Vascular Platelet Hemostasis Disorders and Typical Autoantibodies in Hepatic Cirrhosis at the Outcome of Autoimmune Hepatitis in Children
-
Abstract Number: NUR 01.4
The DATCH Project: Developmentally Appropriate Tools for Children with Hemophilia to Help Them Better Understand Their Disease
-
Abstract Number: PO149
The Detection of Hemophilia C in a 66-year-Old Patient with Postoperative Urinary Bleeding
-
Abstract Number: PB0558
The Devil is in the Detail: An Irish Approach to Switching to Emicizumab Prophylaxis in an Adult Comprehensive Care Centre (CCC)
-
Abstract Number: PB1058
The Diagnostic Utility of the Taipan Snake Venom Time in an Era of DOACstop™
-
Abstract Number: OC 22.2
The Difference in the Transglutaminase Activities of Proteolytically and Non-proteolytically Activated FXIII A is Dependent on the Substrates
-
Abstract Number: PB0780
The Distribution of Anti-platelet Membrane Glycoprotein Antibodies Subtypes in Children with Primary Immune Thrombocytopenia and its Relationship with Therapeutic Effect
-
Abstract Number: PB0297
The Effect of Chronic Anticoagulation and Antiplatelets on COVID-19 Infection
-
Abstract Number: PB0277
The Effect of Covid-19 Lockdown on Patients Taking Warfarin
-
Abstract Number: PB0060
The Effect of Dextran Sulfate in Heparin Monitoring Reagents
-
Abstract Number: PB1047
The Effect of DNase I in Combination with Unfractionated Heparin or Low Molecular Weight Heparin in a Mouse Model of Sepsis
-
Abstract Number: PB0333
The Effect of DOAC StopTM on Measuring Antithrombin Activity
-
Abstract Number: PB0413
The Effect of Lower-leg Trauma and Knee Arthroscopy on the Natural Anticoagulant and Fibrinolytic Systems
-
Abstract Number: PB0053
The Effect of Lower-leg Trauma and Knee Arthroscopy on Thrombin Generation
-
Abstract Number: OC 20.3
The Effect of Platelets on Thrombin Generation in the Premature Infant: The EVENT Study
-
Abstract Number: PB1314
The Effect of Prothrombin Complex Concentrate and Cryoprecipitate on the Frequency and Severity of Multiple Organ Dysfunction Syndrome in Massive Obstetric Haemorrhage
-
Abstract Number: PB0674
The Effect of rFVIIa and Mim8 Combination in Hemophilia A-like Blood
-
Abstract Number: PB0360
The Effect of Trough Dabigatran Plasma Concentration on Rotational Thromboelastometry Parameters
-
Abstract Number: PB0295
The Effects of COVID-19 Pandemic on Children with Haemophilia
-
Abstract Number: PB1004
The Effects of Iron Deficiency on Platelet Function, Indices, and Clinically Reported Hemostasis: A Prospective Clinical Study of Iron Deficient Women Receiving IV Iron
-
Abstract Number: PB0520
The Efficacy and Prognosticator for Inhibitor Eradication in Hemophilia A Boys with High-titer Inhibitors Using a Low-dose Immune Tolerance Induction Strategy (with or without Immunosuppressants): Data from the National Center for Children’s Health of China
-
Abstract Number: PB1145
The Evaluation of the Children with Intracranial Thrombosis
-
Abstract Number: PB0445
The Experience of Oran University Hospital in Algeria in the Management of Acquired Hemophilia
-
Abstract Number: LPB0039
The Extracellular Protease EpiP from S. aureus Triggers Blood Coagulation by Proteolytically Activating Prothrombin and Platelet Protease-Activated Receptor 1
-
Abstract Number: OC 41.2
The Factor XII-uPAR Axis Drives Ovarian Cancer Maintenance and Progression
-
Abstract Number: LPB0016
The Fibrin(ogen) γ-chain Integrin αIIbβ3 Binding Motif is Dispensable for Platelet Accumulation but Modifies Cross-linking in the Injured Liver
-
Abstract Number: PB0588
The FⅨ Gene Mutation Analysis of Hemophilia B in China Central and Western Regions
-
Abstract Number: PB0039
The FV East Texas Variant Causes Bleeding in a Three Generation Family from Indiana
-
Abstract Number: PB0893
The Glanzmann’s Thrombasthenia Registry (GTR): Safety of Platelet Therapy in Patients with Glanzmann’s Thrombasthenia, with a Focus on Changes in alloimmunization Status
-
Abstract Number: PB0340
The Impact of Inactive FVIII Antigen in Factor VIII Deficient Plasma on the Measurement of FVIII Inhibitors
-
Abstract Number: PB0056
The Impact of Lower-leg Injury and Knee Arthroscopy on Procoagulant Factor Levels
-
Abstract Number: PB0554
The Impact of PK-guided Prophylaxis on Clinical Outcomes and Resource Utilization in Hemophilia A Patients: Real-world Evidence From the CHESS II Study
-
Abstract Number: PB0651
The Impact of Platelet αIIbβ3 on the Hemostatic Efficacy of Platelet-derived FVIII Gene Therapy
-
Abstract Number: PB1078
The Impact of Strong Inducers on Direct Oral Anticoagulant Plasma Levels: A Retrospective Study
-
Abstract Number: LPB0046
The Impact of the ABO Blood Group on Postpartum Haemorrhage Risk among Women with Thrombocytopenia
-
Abstract Number: PB0772
The Importance of Follow up Post PE
-
Abstract Number: PB0664
The Importance of Patient Preferences and Other Patient-Centric Metrics in Developing and Evaluating New Haemophilia Treatments
-
Abstract Number: OC 52.1
The Importance of the GPIbα Intracellular Tail in VWF-mediated Platelet Signaling Events and Platelet/Neutrophil Interactions
-
Abstract Number: LPB0060
The Incidence of Severe Infusion Reactions Associated with Common Iron Repletion Strategies
-
Abstract Number: PB1292
The Influence of Thrombophilic Anamnesis and Thrombotic Complications Heredity
-
Abstract Number: PB0768
The Intact Heavy Chain of Plasminogen Supresses Angiogenesis More Strongly than the Known Angiostatin
-
Abstract Number: OC 37.4
The Intracellular Tail of GPIbα Augments GPVI-mediated Signaling in Mice
-
Abstract Number: PB0167
The Kallikrein-kinin System in Bronchoalveolar Lavage Fluid from Patients with COVID-19
-
Abstract Number: OC 12.1
The Khorana Score Is a Marker of Poor Cancer Prognosis, Independent of Development of VTE
-
Abstract Number: OC 68.3
The Link between Inflammation, Coagulation and Endothelium Damage in COVID-19: Evidence from an Exploratory Cross-sectional Study
-
Abstract Number: LB 01.4
The Management of SubSegmental Pulmonary Embolism without Anticoagulation
-
Abstract Number: PB0727
The Paradoxal Association beetween Congenital FVII Deficiency and Thromboembolism
-
Abstract Number: PB0575
The Potential Benefits of Physical Exercises for Reducing Pain in Adult Haemophilic Arthropathy Patients: A Meta-analysis of Randomized Controlled Trials
-
Abstract Number: LPB0085
The Predominant Role of Arrestin3 in General GPCR Desensitization in Platelets
-
Abstract Number: PB0327
The Prevalence of Gene Polymorphism of the Cytochrome P-450 and VKORC1 System among the Indigenous Population of the Arctic
-
Abstract Number: OC 71.3
The Procoagulant and Fibrinolytic Balance of Microvesicles Predicts Mortality in Septic Shock Patients
-
Abstract Number: OC 50.4
The Prognostic Value of ADAMTS13 and von Willebrand Factor in COVID-19 Patients: A Prospective Study by Care Setting
-
Abstract Number: OC 23.3
The Prognostic Value of Symptoms and Performance Status in Ambulatory Cancer Patients and Unsuspected Pulmonary Embolism: Analysis of an International, Prospective, Observational Cohort Study
-
Abstract Number: PB0996
The Proteasome Inhibitor, Bortezomib Induces Apoptosis and Activation in Gel Filtered Human Platelets
-
Abstract Number: OC 19.3
The R543L Protein Altering Variant in the FII Gene (F2) Is a Major Determinant of Coagulation Potential in Mexican Americans
-
Abstract Number: PB0338
The Red Blood Cell Paradox in Viscoelastic Coagulation Tests – Hemoglobin Concentration as a Confounder for Test Reliability?
-
Abstract Number: PB0050
The Relationship of 4 Factor PCC or Plasma to INR and Factor Levels: An Exploratory Analysis of 2 Clinical Trials
-
Abstract Number: PB1109
The RIETE Score: A Useful Screening Tool for Occult Malignancy in VTE and STP?
-
Abstract Number: LPB0064
The Role of Activated Thrombin Activatable Fibrinolysis Inhibitor on Thrombus Stability in Venous Thromboembolism
-
Abstract Number: OC 34.2
The Role of Acute-phase Circulating miRNAs in Modulating Clinical Outcome in Patients with Venous Thromboembolism
-
Abstract Number: PB0275
The Role of D-dimer in Prognosis of Patients with Pulmonary Thrombembolism: Some Aspects for COVID-19
-
Abstract Number: PB0569
The Role of Familial Mediterranean Fever in Hemophilia: Should We Tested?
-
Abstract Number: PO192
The Role of Hydroxychloroquine in a Secondary Prevention of Recurrent Thrombosis in Patient with Thrombophilia and Antiphospholipid Syndrome. A Case Report
-
Abstract Number: PB0956
The Role of Matrix-metalloproteinase 9 in Bone Marrow Remodeling after Total Body Irradiation and Hematopoietic Stem Cell Transplantation
-
Abstract Number: PB1039
The Role of Nitric Oxide and Cationic Groups in Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent
-
Abstract Number: PB1020
The Role of Platelet CLEC-2 and GPVI in Rhabdomyolysis-induced Acute Kidney Injury
-
Abstract Number: OC 07.2
The Role of Point-of-Care Musculoskeletal Ultrasound for Routine Joint Evaluation and Management Considerations in Hemophilia Clinic
-
Abstract Number: PB1089
The Role of Primary Thromboprophylaxis in People with Cancer: A Systematic Review and Meta-analysis
-
Abstract Number: LPB0033
The Role of RAP1 Signaling in Platelet-coagulation Interplay
-
Abstract Number: PB0968
The Role of Septins in Platelet Structure and Function
-
Abstract Number: PB0007
The Role of TEC Family Kinases in oxLDL-mediated Platelet Activity in vitro and Platelet and Endothelial Dysfunction in vivo
-
Abstract Number: OC 41.4
The Role of the Thrombin/PAR Axis in the Anti-tumor CD8+ T Cell Response Following Immune Checkpoint Inhibition Therapy
-
Abstract Number: PB0250
The Role of Thromboelastography and Follow-up of Fibrinolysis in Evaluating the Course of the Disease, Treatment Response, and Outcome of Pediatric Patients with COVID-19
-
Abstract Number: PO119
The Role of Thromboelastography in Search for Drug-candidates
-
Abstract Number: PB1104
The Role of Thrombophilia in Asparaginase Related Venous Thromboembolism in Pediatric and Young Adult Patients Affected by Acute Lymphoblastic Leukemia
-
Abstract Number: PB1165
The Role of Thrombophilia in Deep Vein Thrombosis of Unusual Sites
-
Abstract Number: PB1043
The Role of Transforming Growth Factor ß1 (TGFß1) and Fibrinogen in the Induction of Adhesive Properties of Vascular Endothelium (HUVECS) and the Spread of Acute Lymphoblastic Leukemia (ALL)
-
Abstract Number: OC 38.1
The Role of VWF/FVIII Association in Anti-FVIII Immune Responses in Hemophilia A Mice
-
Abstract Number: PB1196
The Roles of Individual and Neighborhood Income on Regional and Racial Differences in Risk of Venous Thromboembolism in the United States: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS)
-
Abstract Number: PB0547
The Safety of Eptacog Beta in Hemophilia Patients with Inhibitors in Adult, Pediatric, and Perisurgical Settings
-
Abstract Number: PB0829
The Spectrum of Immune Thrombocytopenia with COVID-19 Infection
-
Abstract Number: PB0128
The Thickness of Fibrin Fibers is Associated with High Fibrin Clot Visco-elasticity in Carcinomatosis Patients
-
Abstract Number: OC 58.3
The Tumor Promoting Activity of Osteopontin Is Solely Dependent on its Cleavage by Thrombin
-
Abstract Number: PB1123
The Use of DOACS in Catheter Related Thrombosis in Cancer
-
Abstract Number: PB0431
The Use of Emicizumab for Acquired Hemophilia A at US Hemophilia Treatment Centers
-
Abstract Number: PB1056
The Utility of the Dilute Prothrombin Time Assay in the Diagnosis of Antiphospholipid Syndrome
-
Abstract Number: PB0841
The Value of a Rapid, On-demand ADAMTS13 Activity Assay for the Diagnosis of Thrombotic Thrombocytopenic Purpura
-
Abstract Number: PB0944
The von Willebrand Disease-Woman (VWD-Woman) Trial: A Pilot Study Comparing Recombinant von Willebrand Factor (rVWF) plus Tranexamic Acid (TA) vs. rVWF Alone in the Prevention of Postpartum Hemorrhage in Women with von Willebrand Disease
-
Abstract Number: LB 02.1
The VWF-A1 domain binding aptamer BT200 prolongs the half-lives of different factor VIII (FVIII) products in patients with severe hemophilia A and increases FVIII levels in non-severe hemophilia A
-
Abstract Number: PB0661
The World Federation of Hemophilia Gene Therapy Registry
-
Abstract Number: OC 48.3
Therapeutic Knockdown of Plasminogen with siRNA in Hemophilia A and von Willebrand disease Mouse Models
-
Abstract Number: PB0818
Therapeutic Landscape in Primary Immune Thrombocytopenia (ITP) over the Last Three Decades in the United Kingdom (UK Adult Primary ITP Registry Project)
-
Abstract Number: PB0403
Thermal Shift Assay to Probe Melting of Thrombin, Fibrinogen, Fibrin Monomer and Fibrin: Gly-Pro-Arg-Pro Induces a Fibrin Monomer-like State in Fibrinogen
-
Abstract Number: PB0846
Thirty-five Years of Follow up of a Patient with Congenital Thrombotic Thrombocytopenic Purpura
-
Abstract Number: OC 12.2
Three Available Risk Scores Modestly Predict Hemorrhage in Patients with Cancer-associated Thrombosis (CAT)
-
Abstract Number: PB0307
Thrombin Generation (TG) Reveals Underlying Hypercoagulable Process in COVID-19 Patients Despite Low Molecular Weight Heparin (LMWH) Therapy
-
Abstract Number: OC 18.4
Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements: A Prospective Multicenter Cross-sectional Study
-
Abstract Number: PB0105
Thrombin Generation Assay in Crohn Disease
-
Abstract Number: PB0465
Thrombin Generation by Genesia in Patients with Haemophilia A and Inhibitors during Immune Tolerance Induction
-
Abstract Number: PB0543
Thrombin Generation Capacity of Patients with Severe Haemophilia Receiving Prophylaxis (HOPE Study)
-
Abstract Number: PB0613
Thrombin Generation in Hemophilia A Patients after Infusion of Recombinant and PlasmadDerived Factor VIII Concentrates
-
Abstract Number: PB1157
Thrombin Generation in Newly Diagnosed Multiple Myeloma
-
Abstract Number: PB0124
Thrombin Generation is Affected by Freezing Independent of Storage Temperature
-
Abstract Number: PB0156
Thrombin Generation Kinetics, Neutrophil Extracellular Traps, and von Willebrand Factor in COVID-19 Associated Coagulopathy: A Pilot Study
-
Abstract Number: OC 14.4
Thrombin Generation Rescued in Hemophilia A by Low-normal Levels of FV Is Confirmed to Be Partially due to Substrate Competition
-
Abstract Number: PB1291
Thrombin Generation Test and Use of Combined Oral Contraceptive
-
Abstract Number: OC 77.4
Thrombin Mediated Activation of Protease Activated Receptor 1 Contributes to Doxorubicin Induced Cardiac Injury
-
Abstract Number: OC 27.1
Thrombin Spatial Distribution Determines the Contribution of Activated Protein C to Endogenous Anti-coagulant Activity during Hemostasis and Thrombosis in vivo
-
Abstract Number: LPB0144
Thrombocytopenia in Pregnancy: Identification and Management at a Reference Centre in Pakistan
-
Abstract Number: PB0419
Thromboelastography for the Evaluation and Management of Patients with Traumatic Brain Injury
-
Abstract Number: PB0669
Thromboelastography to Monitor Periprocedural Hemostasis in Advanced Liver Disease: A Systematic Review and Meta-analysis
-
Abstract Number: PB1094
Thromboembolic and Bleeding Complications fFowing Surgery among Patients with Ovarian Cancer – A Single Centre Retrospective Cohort Study
-
Abstract Number: PB1284
Thromboembolic disease (VTE) and Inmune Trombocytopenia (ITP): A Case Report
-
Abstract Number: PB0721
Thromboembolic Disease in Severe Factor V (FV) Deficiency: A Case Report: “Anticoagulating the Anticoagulable”
-
Abstract Number: PB0292
Thromboembolism and Coagulopathy in COVID-19: A Review of Quality Indicators at Sunnybrook Health Sciences Centre
-
Abstract Number: PB1190
Thromboembolism is Prevalent and Adversely Affects Overall Survival in Adults with Hemophagocytic Lymphohistiocytosis
-
Abstract Number: PB1007
Thrombogenic Potential in Patients Undergoing Hemodialysis Using Central Venous Catheter and Arteriovenous Fistula
-
Abstract Number: PB0422
Thrombolysis and Anti-cancer Activity of Koji-Natto (Kojikinase)
-
Abstract Number: PB0424
Thrombolytic Activity of Pearl-like Tempeh
-
Abstract Number: PO166
Thrombophilia and Thromboembolic Venous Disease in Southern Tunisia
-
Abstract Number: PB1293
Thromboprophylaxis in High-risk Obese Pregnant Women: How Much Is Enough?
-
Abstract Number: PB0237
Thrombosis and Bleeding in Critically Ill COVID-19 Patients at Higher than Prophylactic Dose of Heparins
-
Abstract Number: PO184
Thrombosis in Elderly: Watch out Antipsychotic Agents!
-
Abstract Number: PB1135
Thrombotic and Hemorrhagic Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
-
Abstract Number: LPB0123
Thrombotic Complications in a Cohort of Children with Myeloproliferative Neoplasms
-
Abstract Number: OC 40.1
Thrombotic Complications in Pediatric Patients Hospitalized with COVID-19 Disease or Associated Multisystem Inflammatory Syndrome in Children (MIS-C)
-
Abstract Number: PB0147
Thrombotic Events in COVID-19 Are Associated with a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity
-
Abstract Number: PB0881
Thrombotic Microangiopathies (TMA): In vivo Evidence for Platelet Activation and Endothelial Cell Injury, and Potential for Therapeutic Intervention with Defibrotide
-
Abstract Number: PB0163
Thrombotic Microangiopathy in Two Patient with Covid 19 Disease
-
Abstract Number: PB0212
Thrombotic Risk of Hospitalized Patients with COVID-19 and a Co-infection
-
Abstract Number: PB0815
Time Course of Response to Fostamatinib, an Oral Spleen Tyrosine Kinase (SYK) Inhibitor for the Treatment of Immune Thrombocytopenia (ITP)
-
Abstract Number: PB0142
Time Course of the Development of Immunothrombosis during COVID-19 Hospitalization
-
Abstract Number: PB0560
Time from the Inhibitor Detection to the Start of Immune Tolerance Induction and the Outcome of Immune Tolerance Induction: Results from the Brazilian Immune Tolerance (BrazIT) Study
-
Abstract Number: PB0553
Tissue Factor Pathway Inhibitor (TFPI) Levels and Bleeding Risk in Patients with Severe Hemophilia A or B
-
Abstract Number: PB0153
Tissue Factor-stimulated Plasma Thrombin Generation Is Enhanced in Hospitalised Patients with COVID-19 Despite Pharmacological Thromboprophylaxis
-
Abstract Number: PB0008
Tissue Inhibitor of Metalloproteinases-1 (TIMP1) is Related to Residual Thromboxane Dependent Platelet Activation in Patients with Type 2 Diabetes Mellitus Receiving Low Dose Aspirin
-
Abstract Number: LPB0005
Tissue-engineered Human Arteries Replicate Primary and Secondary Haemostatic Functions Seen in vivo: A Replacement for Mouse Arterial Thrombosis Models?
-
Abstract Number: PB0075
Titanium Compounds Bind and Activate Factor XII and Prekallikrein
-
Abstract Number: PB0441
To Treat or Not? Remission Induction of Acquired von Willebrand Syndrome Secondary to Chronic Lymphocytic Leukemia: A Case Report
-
Abstract Number: LB 02.2
Towards Understanding ChAdOx1 nCov-19 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)
-
Abstract Number: PB0410
Tranexamic acid for Hyperacute Primary Intracerebral Haemorrhage (TICH-3): Protocol for a Multinational Phase 3 Placebo-controlled Randomised Trial
-
Abstract Number: PB0412
Tranexamic Acid to Reduce Bleeding in Patients Treated with Non-Vitamin K Oral Anticoagulants Undergoing Dental Extraction: The EXTRACT-NOAC Randomized Clinical Trial
-
Abstract Number: OC 31.1
Transcription Factor RUNX1 Regulates Factor XIIIA Subunit (F13A1) Expression in Platelets and Megakaryocytic Cells: Decreased Platelet F13A1 Expression and Clot Retraction in RUNX1 Haplodeficiency
-
Abstract Number: OC 13.4
Transcriptional Analysis of the Response to Stimulation in ECFCs Derived from Type 1 VWD Patients
-
Abstract Number: OC 29.4
Transcriptomics and Proteomics to Study the Effect of Hyperactive SRC Kinase during Megakaryopoiesis
-
Abstract Number: PB1290
Transferability of the ETP-based APC Resistance Assay on the ST Genesia System
-
Abstract Number: PB0304
Transient Lupus Anticoagulant Presence in COVID-19 Pneumonia, a Probably Epiphenomenon
-
Abstract Number: OC 14.1
Transplacental Delivery of Maternal FVIII for Induction of FVIII-specific Immune Tolerance
-
Abstract Number: OC 48.2
Transplacental Delivery of Recombinant Fc-fused Factor VIII (rFVIIIFc) in FVIII-deficient Mice
-
Abstract Number: PO112
Treatment of Advanced Atherosclerotic Plaque with Neovascularization Using B-mode Ultrasound-guided HDL-loaded Microbubbles-mediated Low Level Focused Electrohydraulic Shock Wave Sonoporation Therapy and Cholesterol Diet Withdrawal
-
Abstract Number: PB1116
Treatment of Cancer-associated Thrombosis with Six Months of Prophylactic-dose Enoxaparin after Initial Full-dose Anticoagulation: A Pilot Study
-
Abstract Number: LPB0075
Treatment of Catheter-related Arterial Thrombosis in Children: A 15-year Single Center Experience
-
Abstract Number: PB0833
Treatment of Immune Thrombocytopenia (ITP) in the COVID-19 Era: Fostamatinib, an Oral Spleen Tyrosine Kinase (SYK) Inhibitor
-
Abstract Number: PB1115
Treatment of Venous Thromboembolism (VTE) Events with Cancer as a Risk Factor in a Teaching Hospital: 2015 – 2020
-
Abstract Number: PB0518
Treatment Patterns and Clinical Outcomes among Patients with Hemophilia A Treated with Factor VIII Replacement Therapies and Nonfactor Therapy: An Assessment of US Real-world Data
-
Abstract Number: OC 25.1
Trends in Venous Thromboembolism and Death in COVID-19 Positive Patients in 2020
-
Abstract Number: PB1212
Trombophilia and Other Risk Factors of Cerebral Venous Sinus Thrombosis in 255 Patients
-
Abstract Number: PO146
TSUBASA Study: An Observational Study of Emicizumab to Evaluate Physical Activity, Bleeding Events, Quality of Daily Life, and Safety in People with Hemophilia A without FVIII Inhibitors
-
Abstract Number: PB0849
TTP during Pregnancy: Acquired or Late-Onset Congenital? A Diagnostic Challenge
-
Abstract Number: PB0746
Tumor Cell-induced Platelet Aggregation is Sustained by Platelet Entrapment into the Fibrin Network Formed by Thrombin
-
Abstract Number: OC 30.2
Tumor Gene Expression Associates with Venous Thromboembolism in Patients with Pancreatic Cancer
-
Abstract Number: PB1140
Tumor Somatic Mutations as Predictors of CDK4/6 Inhibitor Associated Thromboembolism in Women with Metastatic Breast Cancer
-
Abstract Number: PB0685
Twelve Months of Emicizumab Prophylaxis in a Severe Hemophilia A Man with Inhibitor who Failed Immune Tolerance Induction: Effectiveness, Economic, and Safety Outcomes
-
Abstract Number: PB0683
Twelve Months of Emicizumab Prophylaxis in a Woman with Mild Hemophilia A and Inhibitor: Effectiveness, Safety and Economic Outcome
ISTH 2021 Congress
July 17-21, 2021. Philadelphia, PA.